Finance

Lists
Why is BOT down 10,00%?
Dive Deeper
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0090 AUD
-10,00%
(-0,0010) 1D
10-ноя., 16:10:23 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for BOT...
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
24,86 млн
Avg. vol.
10,01 млн
Volume
16,46 млн
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 млд
No. of employees
11
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
24,86 млн
Avg. vol.
10,01 млн
Volume
16,46 млн
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 млд
No. of employees
11
News stories
From web sources and news partners
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
2026-ж., 27-июл.
Fiscal period
Q4 2026
- / -
Revenue / Est. (AUD)
8,65 млн / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
8,25 млн
8,25 млн
8,65 млн
8,65 млн
Cost of goods sold
2,98 млн
2,98 млн
4,19 млн
4,19 млн
Cost of revenue
2,98 млн
2,98 млн
4,19 млн
4,19 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,32 млн
18,32 млн
19,70 млн
19,70 млн
Operating expense
22,08 млн
22,08 млн
22,30 млн
22,30 млн
Total operating expenses
25,06 млн
25,06 млн
26,49 млн
26,49 млн
Operating income
-16,81 млн
-16,81 млн
-17,85 млн
-17,85 млн
Other non operating income
683,30 миң
683,30 миң
109,28 миң
109,28 миң
EBT including unusual items
-16,60 млн
-16,60 млн
-18,29 млн
-18,29 млн
EBT excluding unusual items
-16,60 млн
-16,60 млн
-18,29 млн
-18,29 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16,60 млн
-16,60 млн
-18,29 млн
-18,29 млн
Net profit margin
-201,11%
-201,11%
-211,46%
-211,46%
Earnings per share
-
-
-
-
Interest and investment income
352,66 миң
352,66 миң
202,18 миң
202,18 миң
Interest expense
-802,39 миң
-802,39 миң
-616,20 миң
-616,20 миң
Net interest expenses
-449,74 миң
-449,74 миң
-414,02 миң
-414,02 миң
Depreciation and amortization charges
593,18 миң
593,18 миң
565,11 миң
565,11 миң
EBITDA
-16,22 млн
-16,22 млн
-17,28 млн
-17,28 млн
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору